Ascendis Pharma (ASND) Reports Q2 Loss of EUR0.55/Share

Ascendis Pharma (NASDAQ: ASND) reported Q2 EPS of (EUR0.55), versus (EUR0.94) reported last year.

For earnings history and earnings-related data on Ascendis Pharma (ASND) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Schwab's May activity shows margin loans nearly double
• Aspire Biopharma to acquire automotive supplier for $30 million